Pricing Log in Create free account

Nuvation Bio Inc. (NUVB) vs Zenas BioPharma, Inc. (ZBIO)

Nuvation Bio Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Nuvation Bio Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.7B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −88.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Nuvation Bio Inc. leads on 7 and Zenas BioPharma, Inc. on 5.

Valuation

Metric NUVB ZBIO Biotechnology median
P/E n/m n/m 8.50
P/S 9.13 n/m 9.71
P/B 6.11 6.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.71 n/m 9.21
Earnings yield (9.76%) (36.44%) (33.15%)
Free cash flow yield (7.79%) (14.51%) (25.50%)

Profitability

Metric NUVB ZBIO Biotechnology median
Gross margin 88.18% — 65.16%
Operating margin (81.00%) 0.00% 0.00%
Net margin (88.19%) 0.00% 0.00%
Free cash flow margin (71.17%) 0.00% 0.00%
Return on equity (47.81%) (199.04%) (56.36%)
Return on assets (21.53%) (97.39%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NUVB ZBIO Biotechnology median
Revenue growth (TTM) 1,083.56% — 6.02%
EPS growth (last fiscal year) 71.56% 29.04% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NUVB ZBIO Biotechnology median
Debt to equity 0.98 1.57 0.00
Current ratio 8.37 9.93 4.72
Net debt to EBITDA 2.26 0.69 0.96

Dividend

Metric NUVB ZBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NUVB ZBIO Biotechnology median
Market cap 1.67b 1.66b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack